Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial.
about
Japanese encephalitis-a pathological and clinical perspectiveBlocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infectionLimited Effects of Type I Interferons on Kyasanur Forest Disease Virus in Cell CultureViral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-AntagonistsNovel approaches and challenges to treatment of central nervous system viral infectionsJapanese encephalitis: the virus and vaccinesReview: A neglected Flavivirus: an update on Zika virus in 2016 and the future direction of researchWest Nile encephalitisInhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonistAlpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survivalIdentification of Residues Critical for the Interferon Antagonist Function of Langat Virus NS5 Reveals a Role for the RNA-Dependent RNA Polymerase DomainProgress on the development of therapeutics against West Nile virusThe NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT SignalingEmerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue virusesZika Virus Infection in Dexamethasone-immunosuppressed Mice Demonstrating Disseminated Infection with Multi-organ Involvement Effectively Treated by Recombinant Type I InterferonsAcute encephalitis in children: Progress and priorities from an Australasian perspective.Emerging viral infections of the central nervous system: part 1.Clinical and prognostic features among children with acute encephalitis syndrome in Nepal; a retrospective study.NEUROLOGICAL INFECTIONS IN THE RETURNING INTERNATIONAL TRAVELER.New Japanese encephalitis vaccines: alternatives to production in mouse brain.Japanese Encephalitis VaccinesTreatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model.A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal.Development of effective therapies against West Nile virus infection.IC51 Japanese encephalitis vaccine.Clinical manifestations and outcomes of West Nile virus infection.Potential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges.Delayed cytosolic exposure of Japanese encephalitis virus double-stranded RNA impedes interferon activation and enhances viral dissemination in porcine cells.Antagonism of type I interferon by flaviviruses.Clinico-laboratory profile and outcome of Japanese encephalitis in Nepali children.Japanese B Encephalitis: An Overview of the Disease and Use of Chimerivax-JE as a Preventative Vaccine.Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases.The epidemiology, clinical features, and long-term prognosis of Japanese encephalitis in central sarawak, malaysia, 1997-2005.A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model.Role of intravenous immunoglobulin administration in Japanese encephalitis.Recent advances in Japanese encephalitisJapanese Encephalitis: A Brief Review on Indian Perspectives
P2860
Q21144539-BC502686-539F-47E2-ADB9-967DDBDB87F8Q24562957-0A350E8B-F121-410A-8C9A-216ECD19B7CEQ26699999-B47CA89F-FFAB-45AD-A2F9-C6B53589153FQ26745547-D3695B14-C306-42FA-85FA-DDF5F649C7BBQ26862449-6E36C07E-1687-45F2-AFB4-083266247287Q27010434-95C84820-2A86-49E3-B073-1EE3B018ECFAQ27011704-0BF26C6F-5197-4F59-90D6-D53CDC4B7A99Q27469711-09DAD4AB-4858-4118-8F82-1F7B357C8044Q27472136-E2330007-83B5-4668-9399-3B12F9C3A301Q27472671-816AF8EC-09F5-40C8-9D81-45279E0A69F3Q27480931-2F1A1953-E593-4FC3-AF94-CECADFB89A85Q27489893-62C47593-4793-48E0-B50F-9A4BF4263BECQ27491054-AE56F2D6-59C1-4F72-BB10-43AEA3003086Q27860800-AAB625B5-B478-4CA9-BC4B-25BC80935AE6Q27883663-015A5C14-57D2-4956-8B7E-ACD75D9EC5B4Q30832727-8DE24965-9CAC-4041-A62C-518159E14FA0Q33866041-FC9E0C14-420E-4E27-AD88-22C7D8CAACC5Q34060950-B2784751-5F02-4086-9CFB-249D37D5D161Q34065518-082FA599-B31E-4D4F-8C57-73326F3DECD2Q34173039-F19B93D5-F6F9-49C2-B39A-97E118DCFE7AQ34466587-80BC402F-F7FF-4979-ACA1-F999D6255BDAQ34933362-322BF6FA-BB48-4BB2-876C-398ADDA84138Q35464299-F826F861-FBE9-43CD-8896-3C21128A4B3DQ36322125-E835DEFB-DF80-428F-BC56-BADE7BB6733EQ37519659-2CB3DCF0-91B9-4C27-8B5A-88E54AB9D137Q37611824-F4703A69-B238-4225-B9B4-1AF2BF7ACDDEQ38544126-E2B94DF4-F8DA-4AFA-AC02-FBC8177DE5B9Q38995296-0DA3BC04-734F-47C9-9ADF-592B1DE579EFQ39347222-119ACCD7-E53F-414B-B617-1FE64CEAD265Q39387338-1E70A09D-5106-43EB-BCB4-CE5E38FC13E7Q40196301-C853DE27-97AF-4237-BFFF-5EDE85C163D2Q40505199-BB8CC5CF-066B-4D5E-8FED-B25FEA676CE7Q40514804-D5546BAE-1E64-4012-BD5D-9B501B0BD5DEQ42979827-805E0C0A-2FD6-4013-A49A-927815A75804Q43000958-6D4E6C25-E933-4DFD-95E5-03CC10382715Q43033674-1EB20F1C-6C09-4E05-AC91-D7895D76AB98Q56555782-DD163105-8220-454C-BFA0-B3A87E7A7DFEQ57131014-840578CE-3B2B-43AE-AA49-FF10DE043E88
P2860
Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Interferon alfa-2a in Japanese ...... lind placebo-controlled trial.
@en
Interferon alfa-2a in Japanese ...... lind placebo-controlled trial.
@nl
type
label
Interferon alfa-2a in Japanese ...... lind placebo-controlled trial.
@en
Interferon alfa-2a in Japanese ...... lind placebo-controlled trial.
@nl
prefLabel
Interferon alfa-2a in Japanese ...... lind placebo-controlled trial.
@en
Interferon alfa-2a in Japanese ...... lind placebo-controlled trial.
@nl
P2093
P50
P1433
P1476
Interferon alfa-2a in Japanese ...... lind placebo-controlled trial.
@en
P2093
David W Vaughn
Ha Thi Loan
Mary Gainsborough
Nguyen Minh Dung
Rachel Kneen
Tran Thi Nhu Thuy
Tran Vinh Diet
Vo Cong Khanh
P304
P356
10.1016/S0140-6736(03)12709-2
P407
P577
2003-03-01T00:00:00Z